Azenta (AZTA) Cash from Investing Activities Growth (3y) (2013 - 2026)
Azenta (AZTA) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.99% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.86% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 18.69% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -102.03% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.27% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -7.01% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -3.15% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.22% |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | -32.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.79% |
| Mar 31, 2026 | -49.49% |
| Dec 31, 2025 | -13.27% |
| Jun 30, 2025 | -43.13% |
| Mar 31, 2025 | -27.57% |
| Dec 31, 2024 | 83.55% |
| Sep 30, 2024 | 136.96% |
| Jun 30, 2024 | 58.33% |
| Mar 31, 2024 | -357.11% |
| Dec 31, 2023 | 74.01% |
| Sep 30, 2023 | 129.31% |
| Jun 30, 2023 | 200.65% |
| Mar 31, 2023 | 75.11% |
| Dec 31, 2022 | 62.11% |
| Sep 30, 2022 | -37.59% |
| Jun 30, 2022 | 95.11% |
| Mar 31, 2022 | 697.91% |
| Dec 31, 2021 | 64.11% |
| Sep 30, 2021 | -39.09% |
| Jun 30, 2021 | -66.36% |